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Abstract
We report the case of a 60-year-old woman, presenting with left vocal cord
paralysis (VCP). Diagnostic evaluation revealed sarcoidosis to be the under-
lying pathology. Computed tomography (CT) scans exhibited enlarged sub-
carinal, pretracheal, and prevascular lymph nodes as the possible
mechanism of left VCP through compression of the left recurrent laryngeal
nerve. Initial treatment with oral prednisolone and azathioprine led to
remission of symptoms; however, tapering of dosage led to relapse of cough
without any signs of VCP. The dosage of prednisolone was further boosted,
leading to complete remission. A review of literature reveals 20 cases have
been reported to date, with all but one involving the left vocal cord. This is
the first reported case, with a relapse of the disease without a relapse of
VCP, indicating the rarity of sarcoidosis-associated VCP.
Introduction
Sarcoidosis is a multisystemic disease of unknown
aetiology which often involves multiple organs, most com-
monly the lungs and lymph nodes. We report an interest-
ing case, which initially presented as hoarseness of voice
accompanied with cough, weight loss, and enlarged medi-
astinal lymph nodes. Following the diagnosis on mediasti-
noscopic lymph node biopsy, the patient was started on
corticosteroid therapy with significant improvement; how-
ever, tapering of steroid dosage led to relapse of symptoms,
without a relapse of the vocal cord palsy.
Case Report
A 60-year-old, non-smoker, female, known case of hyper-
tension, presented to the Ear, Nose & Throat (ENT) clinic
with a history of hoarseness of voice, significant weight
loss, and chronic cough for the past six weeks. The cough
was dry initially, although at the time of presentation it
turned productive of mucoid sputum. The coughing epi-
sodes were significantly more prevalent during night, and
there was associated shortness of breath on exertion. She
also reported a persistent globus sensation and difficulty in
swallowing. There was no history of fever, night sweats,
rheumatological symptoms, and chronic gastroesophageal
reflux or post nasal drip symptoms. Furthermore, she
reported positive exposure to biomass fuel during her
childhood; however, exposure to pets was unremarkable.
She was treated with montelukast and levofloxacin for
suspected upper respiratory tract infection; however, this
regimen did not improve her symptoms.
The patient’s blood pressure measured 139/70 mmHg,
pulse 76/min, temperature 37.1C, respiratory rate of
17 breaths/min, and arterial oxygen saturation (SpO2) of
97%. Chest examination revealed bilateral vesicular breath
sounds with no added sounds. The rest of the systemic
and general examination was unremarkable.
A bronchoscopy performed outside our institution was
unremarkable and a bronchoalveolar lavage (BAL) was
negative for Acid-Fast Bacilli (AFB) smear, Gene Xpert,
and fungal cultures. The serum angiotensin-converting
enzyme (ACE) was 48 IU/L (reference range: 0–52/IU/L).
Pulmonary functional test (PFT) demonstrated the pres-
ence of a significant restrictive pathology, with forced vital
capacity (FVC) being 52% of the predicted value, forced
expiratory volume in 1 sec (FEV1) 55% of predicted, and
FEV1/FVC ratio being 77%.
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The patient underwent flexible fibre-optic laryngoscopy
which showed a fixed left vocal cord, with no lesion identi-
fied. A computed tomography (CT) scan with contrast of
the thorax revealed bilateral perihilar ill-defined
opacification with multifocal scattered alveolar and nodu-
lar infiltrates. Enlarged mediastinal lymph nodes
(prevascular, pretracheal, paracardiac, and subcarinal) with
calcifications were also noted, with the largest lymph node
in the subcarinal location, measuring approximately
12 mm in the short-axis diameter (Fig. 1). There was no
evidence of any extra-thoracic lesions. A CT-guided core
lung biopsy revealed peri-bronchial non-necrotizing gran-
ulomatous lesions. A diagnosis of pulmonary sarcoidosis
with left vocal cord paralysis (VCP) was made. Due to
financial constraints, and reasonable clinical confidence in
diagnosis, a fluorodeoxyglucose–positron emission tomog-
raphy (FDG–PET) was not performed. The patient was
started on oral prednisolone at 0.5 mg/kg/day.
She responded well to corticosteroid therapy with com-
plete resolution of symptoms. A follow-up PFT, two
months post-initiation of therapy, showed markedly
improved pulmonary function with FVC being 71% of
predicted, FEV1 71% of predicted, and FEV1/FVC ratio
being 81%. The corticosteroid therapy was tapered to a
maintenance dose of 5 mg/day and the patient was started
on azathioprine (100 mg/day).
The patient presented with relapse of symptoms of
cough within few weeks of maintenance therapy. The
patient denied any presence of dysphonia or hoarseness of
voice. Repeat PFTs revealed marked deterioration, with
FVC being 63% of predicted, FEV1 57% of predicted, and
FEV1/FVC ratio being 91% predicted. A high-resolution
CT (HRCT) chest revealed an ill-defined bilateral, perihilar
patchy opacification with multifocal scattered alveolar/
nodular infiltrates demonstrating mild interval progression
in the right perihilar region, along with enlarged calcified
mediastinal lymph nodes (including the paracardiac lymph
nodes). The patient was again started on 30 mg/day pred-
nisolone and this resulted in significant improvement of
symptoms. To prevent further relapse, another immuno-
suppressant (mycophenolate: 1000 mg/day) was added to
the treatment regimen. Once the patient started showing
clinical improvement, the corticosteroid therapy was grad-
ually tapered to a maintenance dosage 2.5 mg/day.
Discussion
Sarcoidosis is a complex, multisystem, granulomatous dis-
ease of unknown aetiology, ranging from asymptomatic to
life-threatening manifestations. It commonly involves the
lung parenchyma, seen in up to 90% of patients [1]. Laryn-
geal manifestations of the disease remain rare, with
reported incidence between 0.5% and 8.3% [2].
Among the potential laryngeal manifestations, sup-
raglottic and subglottic involvement is usually implicated,
with disease rarely affecting the true vocal cords [2]. Liter-
ature has shown three mechanisms involved with the
development of VCP in sarcoidosis [3–7]. The first mecha-
nism involves direct invasion of vocal cords by granuloma-
tous tissue. This is considerably rare as the spread of
sarcoidosis is mediated through the reticuloendothelial sys-
tem and the true vocal cords are devoid of lymphatics. At
present, only two cases of VCP due to direct invasion are
reported in literature [2,5]. In both cases, the direct inva-
sion of granulomatous tissue affected both true vocal
cords. Subglottic and supraglottic areas were also involved,
suggesting contiguous spread to the true vocal cords from
these areas. The second mechanism is a rare manifestation
of sarcoidosis, known as neurosarcoidosis, whereby there
is presence of polyneuritis of the cranial nerves. The third
mechanism relates to the compression of the recurrent
laryngeal nerves by enlarged mediastinal lymph nodes.
This is the most common mechanism reported in 12 out of
19 cases of sarcoidosis with VCP [2,4,5]. The aetiology in
Figure 1. (A) Computed tomography (CT) scan of the chest mediastinal window displaying enlarged, calcified subcarinal lymph node. (B) Lung win-
dow showing right-sided lung parenchymal infiltrates.
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our case also favours compressive lymphadenopathy due to
enlarged paracardiac lymph nodes. Direct invasion of vocal
cords was excluded in our case due to lack of any lesion or
presence of granulation tissue visualized through flexible
fibre-optic laryngoscopy. Previous reports of neuro-
sarcoidosis used magnetic resonance imaging (MRI) scans
to diagnose neurosarcoidosis, which is the most sensitive
modality [4]. In the current case, while neurosarcoidosis
could not be excluded completely (due to lack of MRI stem-
ming from financial concerns), this diagnosis remained
unlikely due to the lack of any aberrant cranial neve or cen-
tral nervous system (CNS) signs and symptoms or any CNS
lesions visualized through CT imaging of the brain.
VCP may be unilateral or bilateral. Left VCP (LVCP) is
most commonly reported, due to external compression of
the recurrent laryngeal nerves. The left recurrent laryngeal
nerve is longer than the right (12 vs. 6 cm) as it loops
around the arch of the aorta and is more likely to be com-
pressed by the mediastinal lymph nodes that are enlarged
in sarcoidosis [6]. On the other hand, the right recurrent
laryngeal nerve courses around the right subclavian artery
and is less likely to be compressed. To date, only a single
case has been reported with isolated right VCP (RVCP),
with the suspected cause being compression of the right
recurrent laryngeal nerve from the right para-tracheal
lymph nodes [8]. Among the three listed causes of VCP,
only two, compressive lymphadenopathy and vagal neuro-
sarcoidosis, have been implicated in unilateral VCP
(Table 1).
Bilateral VCP (BVCP) is less common than unilateral
VCP, with eight reported cases in literature [4,5]. BVCP is
significantly more dangerous than unilateral VCP as it
may lead to critical airway compromise, as reported by
Hintze et al. [5]. Among the reported cases of BVCP, three
were due to bilateral vagal neurosarcoidosis, three were
due to compressive lymphadenopathy, and two were due
to bilateral direct granulomatous invasion (Table 2).
A review of literature reveals that the average age of pre-
sentation is 49, with 60% of patients being female (12 out
of 20 cases). Left vocal cord involvement has been present
in all but one case of sarcoidosis-associated VCP (19 out
of 20 cases).
For pulmonary sarcoidosis, systemic glucocorticoids
remain the mainstay first-line therapy [18]. As per consen-
sus statement by the American Thoracic Society, European
Respiratory Society, and World Association of Sarcoidosis
and Other Granulomatous Disorders, the initial dose is
20–40 mg/day with eventual tapering, and discontinuation
of therapy in 6–12 months [19]. In some cases, a mainte-
nance dose is required for longer duration, as in our case
to prevent relapse of symptoms. Even after corticosteroid
therapy, vocal cord palsy may persist with resolution of
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out of 20 cases. In the seven cases of persistence, four were
cases of LVCP, two were cases of BVCP, and one was a
case of partially treated sarcoidosis associated BVCP where
the RVCP persisted. In cases of recurrence or persistence
of the vocal cord palsy, it is important for the physician to
consider the aetiology of the vocal cord palsy. Surgical
measures, such as lymphadenectomy, may be required to
improve the quality of life. Boyd et al. reported a case of
unilateral RVCP, which was cured following
lymphadenectomy, as the compressive force on the right
recurrent laryngeal nerve was relieved [8]. Less invasive
measures such as laryngoplasty with injection of micron-
ized dermis and speech and language therapy have also
proven useful in improving the dysphonia [4,6].
In our case, the patient initially responded well to the
corticosteroid therapy, with complete resolution of
symptoms. However, on maintenance dosage of prednis-
olone, there was relapse of disease. Interestingly, there
was no relapse of the left vocal cord palsy. This is in
spite of the repeat HRCT scan showing enlarged, calci-
fied mediastinal lymph nodes (including paracardiac
lymph nodes) that may have possibly compressed the left
recurrent laryngeal nerve. This is particularly unusual as
the presumptive cause of the initial LVCP had been com-
pression of the left recurrent laryngeal nerve by enlarged
mediastinal lymph nodes (primarily by the paracardiac
lymph nodes), which remained persistent. In all previous
cases of treated LVCP (due to compressive lymphade-
nopathy), resolution of lymphadenopathy leads to reso-
lution of the LVCP.
In conclusion, we report a case of sarcoidosis associ-
ated with LVCP which resolved following oral cortico-
steroid therapy despite persistence of enlarged
mediastinal lymph nodes and later relapse of the disease.
The above literature demonstrates that sarcoidosis-
associated VCP remains an exceedingly rare presenta-
tion, it must be recognized and appropriately managed
by clinicians.
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